Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.

Bégin-Lavallée V, Midavaine É, Dansereau MA, Tétreault P, Longpré JM, Jacobi AM, Rose SD, Behlke MA, Beaudet N, Sarret P.

Mol Pain. 2016 Jun 15;12. pii: 1744806916653969. doi: 10.1177/1744806916653969. Print 2016.

2.

Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.

Klose D, Saunders U, Barth S, Fischer R, Jacobi AM, Nachreiner T.

BMC Biotechnol. 2016 Feb 17;16:18. doi: 10.1186/s12896-016-0249-x.

3.

Impact of air and water vapor environments on the hydrophobicity of surfaces.

Weisensee PB, Neelakantan NK, Suslick KS, Jacobi AM, King WP.

J Colloid Interface Sci. 2015 Sep 1;453:177-85. doi: 10.1016/j.jcis.2015.04.060. Epub 2015 May 4.

PMID:
25985421
4.

Gβ4γ1 as a modulator of M3 muscarinic receptor signalling and novel roles of Gβ1 subunits in the modulation of cellular signalling.

Khan SM, Min A, Gora S, Houranieh GM, Campden R, Robitaille M, Trieu P, Pétrin D, Jacobi AM, Behlke MA, Angers S, Hébert TE.

Cell Signal. 2015 Aug;27(8):1597-608. doi: 10.1016/j.cellsig.2015.04.007. Epub 2015 Apr 23.

PMID:
25916507
5.

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.

Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM.

Arthritis Res Ther. 2015 Apr 3;17:92. doi: 10.1186/s13075-015-0603-8.

6.

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides.

Hammond SM, McClorey G, Nordin JZ, Godfrey C, Stenler S, Lennox KA, Smith CI, Jacobi AM, Varela MA, Lee Y, Behlke MA, Wood MJ, Andaloussi SE.

Mol Ther Nucleic Acids. 2014 Nov 25;3:e212. doi: 10.1038/mtna.2014.63.

7.

Kir3 channel ontogeny - the role of Gβγ subunits in channel assembly and trafficking.

Zylbergold P, Sleno R, Khan SM, Jacobi AM, Belhke MA, Hébert TE.

Front Cell Neurosci. 2014 Apr 14;8:108. doi: 10.3389/fncel.2014.00108. eCollection 2014.

8.

[Rituximab for treatment of Felty’s syndrome].

Becker H, Appel H, Fassbinder T, Heitzmann D, Willeke P, Jacobi AM.

Z Rheumatol. 2014 Jun;73(5):465-6, 468. German.

PMID:
24659095
9.

Imaging of fetal thymus in pregnant women with rheumatic diseases.

Warby AC, Amler S, Jacobi AM, Hammer K, Möllmann U, Falkenberg MK, Möllers M, Kiesel L, Klockenbusch W, Schmitz R.

J Perinat Med. 2014 Sep;42(5):635-9. doi: 10.1515/jpm-2013-0314.

PMID:
24552965
10.

Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.

Sarvestani ST, Tate MD, Moffat JM, Jacobi AM, Behlke MA, Miller AR, Beckham SA, McCoy CE, Chen W, Mintern JD, O'Keeffe M, John M, Williams BR, Gantier MP.

J Virol. 2014 Jan;88(2):799-810. doi: 10.1128/JVI.01571-13. Epub 2013 Nov 13.

11.

Spinal NTS2 receptor activation reverses signs of neuropathic pain.

Tétreault P, Beaudet N, Perron A, Belleville K, René A, Cavelier F, Martinez J, Stroh T, Jacobi AM, Rose SD, Behlke MA, Sarret P.

FASEB J. 2013 Sep;27(9):3741-52. doi: 10.1096/fj.12-225540. Epub 2013 Jun 11.

12.

Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.

Ramachandran S, Karp PH, Osterhaus SR, Jiang P, Wohlford-Lenane C, Lennox KA, Jacobi AM, Praekh K, Rose SD, Behlke MA, Xing Y, Welsh MJ, McCray PB Jr.

Am J Respir Cell Mol Biol. 2013 Oct;49(4):544-51. doi: 10.1165/rcmb.2012-0430OC.

13.

Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.

Ramachandran S, Krishnamurthy S, Jacobi AM, Wohlford-Lenane C, Behlke MA, Davidson BL, McCray PB Jr.

Am J Physiol Lung Cell Mol Physiol. 2013 Jul 1;305(1):L23-32. doi: 10.1152/ajplung.00426.2012. Epub 2013 Apr 26.

14.

[Interleukin-1-mediated diseases].

Holzinger D, Becker H, Jacobi AM.

Internist (Berl). 2013 Apr;54(4):408-15. doi: 10.1007/s00108-012-3186-3. German.

PMID:
23460390
15.

Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.

Fernandez G, Zaikos TD, Khan SZ, Jacobi AM, Behlke MA, Zeichner SL.

J Virol. 2013 Apr;87(7):3966-78. doi: 10.1128/JVI.03251-12. Epub 2013 Jan 30.

16.

Deep Sequencing Analyses of DsiRNAs Reveal the Influence of 3' Terminal Overhangs on Dicing Polarity, Strand Selectivity, and RNA Editing of siRNAs.

Zhou J, Song MS, Jacobi AM, Behlke MA, Wu X, Rossi JJ.

Mol Ther Nucleic Acids. 2012 Apr 3;1:e17. doi: 10.1038/mtna.2012.6.

17.

[B-cell-directed therapy in patients with connective tissue diseases].

Jacobi AM, Dörner T.

Dtsch Med Wochenschr. 2012 Sep;137(36):1755-7. doi: 10.1055/s-0032-1305208. Epub 2012 Aug 29. Review. German.

PMID:
22933200
18.

Wetting behavior and drainage of water droplets on microgrooved brass surfaces.

Rahman MA, Jacobi AM.

Langmuir. 2012 Sep 18;28(37):13441-51. doi: 10.1021/la302669g. Epub 2012 Sep 4.

PMID:
22909187
19.

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma.

Weinstein S, Emmanuel R, Jacobi AM, Abraham A, Behlke MA, Sprague AG, Novobrantseva TI, Nagler A, Peer D.

PLoS One. 2012;7(8):e43343. doi: 10.1371/journal.pone.0043343. Epub 2012 Aug 14.

20.

A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator.

Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, Keshavjee S, Lennox KA, Jacobi AM, Rose SD, Behlke MA, Welsh MJ, Xing Y, McCray PB Jr.

Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13362-7. doi: 10.1073/pnas.1210906109. Epub 2012 Aug 1.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk